Clinic
Children's Hospital Medical Center
Children's Hospital Medical Center was paid $386.70M by Medicaid between Jan 2018 and Dec 2024, across 918 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 16% of everything it billed.
33Billing provider infoCHILDREN'S HOSPITAL MEDICAL CENTER
CINCINNATI, OH 45229
CINCINNATI, OH 45229
33aNPI1548212988assigned 05/16/2006
33bProvider typePrimary Care Clinic/Center
28Total paid$386.70M
24GClaims5,296,668
24DCodes billed918
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Ohio
Rank by total paid#1 of 118
Median peer was paid$67K
This provider vs. median5,793×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 465,439 | $32.17M | |
| 2019 | 472,857 | $34.21M | |
| 2020 | 380,682 | $31.38M | |
| 2021 | 567,030 | $39.38M | |
| 2022 | 727,968 | $49.75M | |
| 2023 | 1,481,462 | $106.04M | |
| 2024incomplete | 1,201,230 | $93.77M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 573,206 | 521,812 | $61.84M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.2% | 140,047 | 130,395 | $20.13M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.5% | 163,466 | 155,859 | $17.42M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 141,939 | 127,299 | $14.91M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.9% | 9,913 | 8,472 | $11.19M |
| 96127 | 2.8% | 94,705 | 89,836 | $11.01M | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.8% | 43,712 | 41,484 | $10.90M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.1% | 64,613 | 35,367 | $8.15M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.9% | 102,911 | 39,797 | $7.32M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 46,542 | 43,723 | $6.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.6% | 35,219 | 31,941 | $6.06M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 50,097 | 47,820 | $5.97M |
906 more codes
| 90791 | Psychiatric diagnostic evaluation | 1.5% | 22,350 | $5.89M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.5% | 76,417 | $5.88M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.5% | 5,082 | $5.69M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 62,883 | $5.67M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 47,517 | $5.41M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 45,667 | $5.39M |
| 99215 | Doctor's office visit, returning patient (complex) | 1.4% | 51,303 | $5.36M |
| H2020 | Therapeutic behavioral services, per diem | 1.1% | 28,622 | $4.27M |
| 90837 | Psychotherapy session, about an hour | 1.1% | 31,201 | $4.26M |
| S0201 | Partial hospitalization services, less than 24 hours, per diem | <1% | 5,861 | $3.52M |
| 99219 | <1% | 9,681 | $3.45M | |
| 99285 | Emergency room visit (most serious) | <1% | 13,276 | $3.40M |
| G0378 | Hospital observation service, per hour | <1% | 22,080 | $3.20M |
| 99401 | <1% | 14,397 | $2.87M | |
| H2019 | Therapeutic behavioral services, billed per 15 minutes | <1% | 21,597 | $2.80M |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 4,792 | $2.71M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 6,073 | $2.70M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | <1% | 1,228 | $2.69M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 22,356 | $2.64M |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 12,216 | $2.63M |
| 93325 | <1% | 15,050 | $2.56M | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 3,855 | $2.51M |
| 92551 | <1% | 29,768 | $2.32M | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 3,535 | $2.25M |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15,228 | $2.21M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,184 | $2.15M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 4,592 | $2.14M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 25,260 | $2.13M |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 25,173 | $2.07M |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,003 | $1.98M |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,100 | $1.93M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 48,501 | $1.90M |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 8,545 | $1.78M |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,302 | $1.66M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 98,180 | $1.61M |
| H0036 | Community psychiatric support and treatment, per 15 minutes | <1% | 22,515 | $1.55M |
| D1351 | Sealant - per tooth | <1% | 2,590 | $1.54M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,578 | $1.48M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,722 | $1.45M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 9,449 | $1.44M |
| 42830 | <1% | 1,373 | $1.41M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 11,076 | $1.37M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 39,262 | $1.31M |
| 01922 | <1% | 5,820 | $1.30M | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 888 | $1.30M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 3,426 | $1.29M |
| 31624 | <1% | 1,766 | $1.29M | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 3,433 | $1.23M |
| 95782 | <1% | 1,159 | $1.19M | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 974 | $1.18M |
| 97803 | <1% | 12,468 | $1.13M | |
| 97161 | <1% | 10,782 | $1.11M | |
| 76770 | <1% | 5,809 | $1.10M | |
| 96130 | <1% | 4,008 | $1.03M | |
| 99402 | <1% | 5,011 | $1.00M | |
| 92523 | <1% | 9,711 | $966K | |
| 93308 | <1% | 2,983 | $886K | |
| 92587 | <1% | 9,154 | $881K | |
| A0434 | Specialty care transport (sct) | <1% | 6,226 | $853K |
| J3535 | Drug administered through a metered dose inhaler | <1% | 11,678 | $839K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,244 | $837K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 7,444 | $817K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 4,789 | $809K |
| 95715 | <1% | 1,047 | $763K | |
| 44970 | <1% | 243 | $748K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 32,282 | $738K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 7,255 | $723K |
| J3490 | Unclassified drugs | <1% | 151,600 | $707K |
| 83655 | <1% | 41,011 | $699K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 33,639 | $666K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,872 | $629K |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 19,073 | $628K |
| 87799 | <1% | 5,492 | $618K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 167,877 | $599K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 86,703 | $579K |
| 31622 | <1% | 738 | $573K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 47,507 | $571K |
| 96415 | <1% | 1,398 | $565K | |
| 97802 | <1% | 6,198 | $565K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,126 | $556K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 17,777 | $553K |
| 93304 | <1% | 1,646 | $527K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27,431 | $521K |
| 97165 | <1% | 5,519 | $510K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 21,758 | $508K |
| 29075 | <1% | 3,245 | $503K | |
| 97166 | <1% | 4,451 | $496K | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 12,955 | $477K |
| 67311 | <1% | 209 | $468K | |
| 80053 | Comprehensive metabolic panel | <1% | 32,797 | $467K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 907 | $465K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,693 | $462K |
| 12011 | <1% | 2,086 | $455K | |
| 29065 | <1% | 2,996 | $454K | |
| A0425 | Ground mileage, per statute mile | <1% | 15,534 | $452K |
| D2330 | <1% | 775 | $444K | |
| 31526 | <1% | 1,704 | $434K | |
| 96156 | <1% | 1,603 | $430K | |
| 54163 | <1% | 351 | $426K | |
| 42821 | <1% | 296 | $414K | |
| 97755 | <1% | 4,425 | $407K | |
| 64643 | <1% | 824 | $401K | |
| 96161 | <1% | 9,896 | $399K | |
| 92579 | <1% | 4,566 | $398K | |
| 74183 | <1% | 819 | $387K | |
| 95816 | <1% | 1,915 | $379K | |
| 97750 | <1% | 6,427 | $346K | |
| 96136 | <1% | 2,313 | $341K | |
| 54161 | <1% | 274 | $337K | |
| 94010 | <1% | 9,415 | $333K | |
| 72197 | <1% | 602 | $327K | |
| 87497 | <1% | 2,722 | $322K | |
| 86832 | <1% | 1,567 | $320K | |
| 97162 | <1% | 3,366 | $314K | |
| 92567 | <1% | 18,328 | $313K | |
| 74018 | <1% | 9,592 | $313K | |
| 92526 | <1% | 4,983 | $305K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,536 | $303K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,147 | $303K |
| 92652 | <1% | 2,443 | $297K | |
| 80076 | <1% | 26,203 | $296K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 19,931 | $291K |
| 76820 | <1% | 2,646 | $290K | |
| 81229 | <1% | 1,182 | $288K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 27,469 | $287K |
| 90686 | <1% | 34,017 | $285K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 867 | $285K |
| 12001 | <1% | 1,269 | $282K | |
| 92609 | <1% | 3,761 | $280K | |
| 93320 | <1% | 3,258 | $276K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 778 | $272K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 825 | $267K |
| 93321 | <1% | 5,063 | $265K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 6,487 | $265K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,934 | $264K |
| 74181 | <1% | 748 | $263K | |
| 97164 | <1% | 2,666 | $262K | |
| 29405 | <1% | 1,549 | $259K | |
| 80061 | Lipid panel | <1% | 27,547 | $258K |
| 99457 | <1% | 2,294 | $257K | |
| 17110 | <1% | 1,165 | $256K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 3,958 | $255K |
| 86833 | <1% | 1,554 | $255K | |
| 96367 | <1% | 2,199 | $249K | |
| 80069 | <1% | 18,879 | $248K | |
| 20680 | <1% | 151 | $245K | |
| 93976 | <1% | 1,466 | $243K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,121 | $243K |
| 82728 | <1% | 21,725 | $240K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 20,825 | $236K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 972 | $235K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 20,824 | $235K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72,880 | $235K |
| 97168 | <1% | 2,372 | $234K | |
| 92610 | <1% | 2,841 | $231K | |
| 88313 | <1% | 2,623 | $230K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 13,467 | $226K |
| 78816 | <1% | 143 | $216K | |
| 96112 | <1% | 933 | $206K | |
| 90670 | <1% | 21,772 | $203K | |
| 92555 | <1% | 4,931 | $196K | |
| 72141 | <1% | 568 | $192K | |
| 92582 | <1% | 2,640 | $190K | |
| 88185 | <1% | 1,566 | $190K | |
| 97167 | <1% | 1,396 | $187K | |
| 83735 | <1% | 22,442 | $184K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 36,197 | $181K |
| 80197 | <1% | 5,767 | $179K | |
| 96138 | <1% | 926 | $173K | |
| 76827 | <1% | 1,785 | $172K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 30,584 | $170K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 333 | $169K |
| 74230 | <1% | 1,192 | $167K | |
| 76825 | <1% | 1,375 | $167K | |
| 87505 | <1% | 1,244 | $164K | |
| 00731 | <1% | 2,924 | $162K | |
| 00126 | <1% | 6,258 | $161K | |
| 88184 | <1% | 2,590 | $161K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 1,491 | $157K |
| 84439 | <1% | 11,721 | $153K | |
| 95951 | <1% | 279 | $152K | |
| 43762 | <1% | 927 | $151K | |
| J2997 | Injection, alteplase recombinant, 1 mg | <1% | 587 | $149K |
| 49452 | <1% | 549 | $144K | |
| 73100 | <1% | 6,116 | $144K | |
| 92557 | <1% | 1,303 | $144K | |
| 90651 | <1% | 11,853 | $143K | |
| 82977 | <1% | 25,904 | $139K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 425 | $139K |
| 76536 | <1% | 1,097 | $138K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 23,058 | $138K |
| 83525 | <1% | 7,961 | $137K | |
| 90698 | <1% | 21,440 | $137K | |
| 82610 | <1% | 6,903 | $137K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,047 | $132K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,298 | $132K |
| 90633 | <1% | 16,021 | $131K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 5,297 | $128K |
| 97113 | <1% | 1,195 | $127K | |
| 99155 | <1% | 860 | $127K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,434 | $126K |
| 73090 | <1% | 4,486 | $125K | |
| 95700 | <1% | 1,081 | $125K | |
| 70544 | <1% | 462 | $124K | |
| 00920 | <1% | 2,065 | $123K | |
| 86140 | <1% | 17,358 | $122K | |
| 84100 | <1% | 21,978 | $120K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 108 | $119K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 17,461 | $118K |
| 92611 | <1% | 1,022 | $117K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 3,266 | $116K |
| 95819 | <1% | 492 | $115K | |
| 96202 | <1% | 1,205 | $115K | |
| 72146 | <1% | 471 | $113K | |
| 97763 | <1% | 1,850 | $110K | |
| 74019 | <1% | 3,674 | $109K | |
| 72082 | <1% | 3,007 | $108K | |
| 82784 | <1% | 10,923 | $107K | |
| 94621 | <1% | 521 | $107K | |
| 74712 | <1% | 296 | $104K | |
| 53450 | <1% | 58 | $103K | |
| 51784 | <1% | 589 | $101K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 411 | $101K |
| 86850 | <1% | 4,823 | $101K | |
| 80050 | General health panel | <1% | 1,931 | $97K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,263 | $97K |
| 64642 | <1% | 889 | $97K | |
| 82803 | <1% | 5,118 | $96K | |
| 87650 | <1% | 6,627 | $96K | |
| 83970 | <1% | 3,246 | $95K | |
| D2331 | <1% | 223 | $95K | |
| 90674 | <1% | 9,516 | $95K | |
| 00520 | <1% | 1,369 | $94K | |
| 73521 | <1% | 3,323 | $94K | |
| 76886 | <1% | 684 | $94K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 73 | $94K |
| 96116 | <1% | 333 | $93K | |
| 95811 | <1% | 103 | $93K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,891 | $93K |
| 92133 | <1% | 1,664 | $92K | |
| 96132 | <1% | 320 | $92K | |
| 97760 | <1% | 1,274 | $92K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 5,330 | $91K |
| 0001A | <1% | 2,970 | $90K | |
| 83520 | <1% | 3,892 | $88K | |
| J2704 | Injection, propofol, 10 mg | <1% | 37,468 | $87K |
| Q3014 | Telehealth originating site facility fee | <1% | 4,210 | $87K |
| 88307 | <1% | 643 | $86K | |
| 73630 | <1% | 4,484 | $86K | |
| 71250 | <1% | 359 | $86K | |
| 81025 | <1% | 26,954 | $85K | |
| 86900 | <1% | 5,886 | $85K | |
| 0002A | <1% | 2,516 | $85K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,888 | $84K |
| 96158 | <1% | 1,119 | $84K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 479 | $83K |
| 0071A | <1% | 2,254 | $83K | |
| 83516 | <1% | 6,868 | $83K | |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | <1% | 17 | $82K |
| 86003 | <1% | 3,352 | $82K | |
| 97016 | <1% | 1,894 | $82K | |
| 96125 | <1% | 327 | $81K | |
| 99157 | <1% | 695 | $81K | |
| 29345 | <1% | 473 | $80K | |
| 90681 | <1% | 10,082 | $79K | |
| 86780 | <1% | 9,424 | $79K | |
| D2390 | <1% | 200 | $78K | |
| 70486 | <1% | 433 | $78K | |
| 73070 | <1% | 3,725 | $77K | |
| 83540 | <1% | 11,941 | $77K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 444 | $77K |
| J3262 | Injection, tocilizumab, 1 mg | <1% | 48 | $76K |
| 77075 | <1% | 552 | $76K | |
| 92250 | <1% | 1,971 | $75K | |
| 92553 | <1% | 805 | $75K | |
| D1120 | Dental cleaning, child | <1% | 6,217 | $75K |
| 24640 | <1% | 269 | $75K | |
| 82247 | <1% | 6,231 | $74K | |
| 76881 | <1% | 640 | $74K | |
| 0072A | <1% | 1,959 | $74K | |
| 90839 | <1% | 426 | $74K | |
| 96040 | <1% | 2,120 | $74K | |
| 74240 | <1% | 467 | $73K | |
| 73590 | <1% | 3,492 | $73K | |
| 12002 | <1% | 302 | $72K | |
| 85027 | <1% | 26,351 | $71K | |
| 76870 | <1% | 1,014 | $70K | |
| 90710 | <1% | 6,882 | $69K | |
| 83550 | <1% | 10,583 | $68K | |
| 90744 | <1% | 11,116 | $68K | |
| 93975 | <1% | 327 | $68K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,997 | $68K |
| 99454 | <1% | 609 | $68K | |
| 90619 | <1% | 7,022 | $67K | |
| 73610 | <1% | 4,083 | $67K | |
| 24538 | <1% | 13 | $66K | |
| 74270 | <1% | 389 | $66K | |
| 95117 | <1% | 1,878 | $66K | |
| 00813 | <1% | 938 | $65K | |
| C1769 | Guide wire | <1% | 1,944 | $65K |
| 88346 | <1% | 688 | $65K | |
| 00300 | <1% | 964 | $64K | |
| 90480 | <1% | 1,906 | $64K | |
| 91200 | <1% | 610 | $63K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 5,220 | $63K |
| 85610 | <1% | 9,532 | $63K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,500 | $62K |
| 70360 | <1% | 3,136 | $61K | |
| 90677 | <1% | 5,515 | $60K | |
| 90716 | <1% | 6,145 | $60K | |
| 36591 | <1% | 2,251 | $59K | |
| 87077 | <1% | 6,941 | $59K | |
| 75557 | <1% | 168 | $59K | |
| 90715 | <1% | 6,544 | $59K | |
| 96167 | <1% | 765 | $59K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 8,522 | $58K |
| 51798 | <1% | 1,056 | $58K | |
| 77080 | <1% | 776 | $57K | |
| 92556 | <1% | 1,143 | $57K | |
| 88342 | <1% | 1,578 | $57K | |
| 74455 | <1% | 369 | $57K | |
| 82947 | <1% | 12,963 | $56K | |
| 82607 | <1% | 4,014 | $55K | |
| 72081 | <1% | 1,885 | $55K | |
| 82248 | <1% | 8,503 | $55K | |
| 84403 | <1% | 4,085 | $54K | |
| 96131 | <1% | 3,709 | $54K | |
| 90707 | <1% | 6,263 | $54K | |
| 73140 | <1% | 3,212 | $53K | |
| 81513 | <1% | 314 | $53K | |
| 10060 | <1% | 255 | $53K | |
| 73560 | <1% | 2,932 | $53K | |
| 88341 | <1% | 449 | $52K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,640 | $52K |
| 90685 | <1% | 6,744 | $50K | |
| 11900 | <1% | 246 | $50K | |
| 90648 | <1% | 8,971 | $50K | |
| 82330 | <1% | 4,796 | $49K | |
| 81003 | <1% | 23,956 | $49K | |
| 86481 | <1% | 2,994 | $49K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 447 | $48K |
| 92083 | <1% | 534 | $48K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,657 | $48K |
| 81001 | <1% | 21,495 | $47K | |
| 82542 | <1% | 3,891 | $47K | |
| 84450 | <1% | 13,992 | $47K | |
| 84460 | <1% | 13,817 | $46K | |
| 77072 | <1% | 1,521 | $46K | |
| 86901 | <1% | 5,810 | $45K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 8,763 | $45K |
| 87070 | <1% | 5,925 | $44K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 218 | $44K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 818 | $43K |
| 00320 | <1% | 622 | $43K | |
| 88312 | <1% | 864 | $43K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 50,072 | $43K |
| 36596 | <1% | 83 | $42K | |
| 72170 | <1% | 1,791 | $42K | |
| 85730 | <1% | 6,068 | $41K | |
| 82570 | <1% | 8,148 | $41K | |
| 92552 | <1% | 1,981 | $41K | |
| 88304 | <1% | 1,107 | $41K | |
| 0124A | <1% | 1,126 | $41K | |
| 83605 | <1% | 3,369 | $41K | |
| 73130 | <1% | 2,171 | $41K | |
| 85652 | <1% | 15,717 | $41K | |
| 94060 | <1% | 770 | $40K | |
| 90661 | <1% | 4,843 | $40K | |
| 96450 | <1% | 119 | $40K | |
| 96137 | <1% | 2,286 | $40K | |
| 92504 | <1% | 299 | $39K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 53,913 | $38K |
| 86923 | <1% | 1,064 | $38K | |
| 88108 | <1% | 1,746 | $37K | |
| 97542 | <1% | 370 | $37K | |
| 90723 | <1% | 4,794 | $36K | |
| 83993 | <1% | 1,857 | $36K | |
| 90734 | <1% | 3,113 | $35K | |
| 85240 | <1% | 1,783 | $35K | |
| 54640 | <1% | 21 | $35K | |
| 88300 | <1% | 5,372 | $35K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 419 | $34K |
| 94799 | <1% | 3,161 | $34K | |
| 82785 | <1% | 2,636 | $34K | |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | <1% | 959 | $33K |
| 82670 | <1% | 2,453 | $33K | |
| 72100 | <1% | 1,539 | $33K | |
| 69210 | <1% | 546 | $33K | |
| 90696 | <1% | 6,448 | $32K | |
| 29125 | <1% | 854 | $32K | |
| 00840 | <1% | 490 | $32K | |
| 87186 | <1% | 5,409 | $32K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 43,693 | $32K |
| D1110 | Prophylaxis - adult | <1% | 313 | $31K |
| 70491 | <1% | 76 | $31K | |
| 87641 | <1% | 1,076 | $31K | |
| 77073 | <1% | 1,220 | $31K | |
| 99221 | <1% | 55 | $31K | |
| 86355 | <1% | 1,338 | $31K | |
| 86706 | <1% | 5,716 | $31K | |
| 90700 | <1% | 4,367 | $31K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 35,339 | $31K |
| 99458 | <1% | 542 | $30K | |
| 76506 | <1% | 215 | $30K | |
| 72070 | <1% | 1,427 | $30K | |
| 92522 | <1% | 322 | $30K | |
| 01920 | <1% | 230 | $30K | |
| 88271 | <1% | 383 | $30K | |
| 97014 | <1% | 882 | $30K | |
| 72040 | <1% | 1,784 | $30K | |
| 76821 | <1% | 264 | $30K | |
| 92015 | Determination of refractive state | <1% | 2,377 | $30K |
| 87205 | <1% | 7,962 | $29K | |
| 25565 | <1% | 96 | $29K | |
| 83880 | <1% | 1,247 | $29K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 241 | $29K |
| 84145 | <1% | 2,097 | $29K | |
| 87040 | <1% | 4,464 | $28K | |
| 86803 | <1% | 5,680 | $28K | |
| 99243 | <1% | 389 | $28K | |
| 82550 | <1% | 4,259 | $28K | |
| 87400 | <1% | 982 | $27K | |
| 86360 | <1% | 1,266 | $27K | |
| 86359 | <1% | 1,339 | $27K | |
| 0154A | <1% | 718 | $27K | |
| 82105 | <1% | 1,351 | $27K | |
| 97163 | <1% | 223 | $27K | |
| 82962 | <1% | 4,803 | $27K | |
| 86480 | <1% | 1,309 | $26K | |
| 86357 | <1% | 1,341 | $26K | |
| 83690 | <1% | 6,656 | $26K | |
| 00140 | <1% | 529 | $26K | |
| 84305 | <1% | 1,539 | $26K | |
| 92134 | <1% | 460 | $26K | |
| 93788 | <1% | 293 | $25K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 773 | $25K |
| 0081A | <1% | 704 | $25K | |
| 00120 | <1% | 225 | $25K | |
| 73552 | <1% | 1,567 | $25K | |
| 85046 | <1% | 8,262 | $25K | |
| 87496 | <1% | 486 | $25K | |
| 82746 | <1% | 2,795 | $24K | |
| 83020 | <1% | 2,396 | $24K | |
| 87340 | <1% | 5,496 | $24K | |
| 86038 | <1% | 1,672 | $24K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 6,231 | $24K |
| 87102 | <1% | 2,821 | $24K | |
| 87634 | <1% | 2,187 | $23K | |
| 00400 | <1% | 492 | $23K | |
| 81406 | <1% | 322 | $23K | |
| 87486 | <1% | 954 | $23K | |
| 83519 | <1% | 1,522 | $23K | |
| 81405 | <1% | 357 | $22K | |
| 86665 | <1% | 1,751 | $21K | |
| 81415 | <1% | 29 | $21K | |
| 85245 | <1% | 1,063 | $21K | |
| 85246 | <1% | 1,288 | $21K | |
| 86704 | <1% | 4,668 | $21K | |
| 92607 | <1% | 223 | $21K | |
| 82533 | <1% | 828 | $21K | |
| 92018 | <1% | 18 | $21K | |
| 78264 | <1% | 64 | $20K | |
| 49500 | <1% | 12 | $20K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 6,135 | $20K |
| 85014 | <1% | 4,348 | $20K | |
| 84146 | <1% | 1,444 | $20K | |
| 91320 | <1% | 763 | $20K | |
| 94726 | <1% | 358 | $20K | |
| 95076 | <1% | 47 | $20K | |
| 87581 | <1% | 956 | $20K | |
| 95115 | <1% | 559 | $20K | |
| 00160 | <1% | 258 | $20K | |
| 51701 | <1% | 916 | $19K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 103 | $19K |
| 36592 | <1% | 1,355 | $19K | |
| 72142 | <1% | 96 | $19K | |
| 94618 | <1% | 187 | $19K | |
| 90680 | <1% | 2,169 | $19K | |
| 70480 | <1% | 77 | $19K | |
| 88275 | <1% | 319 | $19K | |
| 73030 | <1% | 1,141 | $19K | |
| 70250 | <1% | 629 | $19K | |
| 54150 | <1% | 14 | $18K | |
| 83002 | <1% | 1,069 | $18K | |
| 84156 | <1% | 4,986 | $18K | |
| 85247 | <1% | 1,115 | $18K | |
| 86849 | <1% | 457 | $18K | |
| 80299 | <1% | 798 | $18K | |
| 90675 | <1% | 53 | $18K | |
| 93505 | <1% | 17 | $17K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,525 | $17K |
| 83001 | <1% | 1,556 | $17K | |
| 92585 | <1% | 46 | $17K | |
| 86160 | <1% | 1,482 | $17K | |
| J3590 | Unclassified biologics | <1% | 190 | $16K |
| 86376 | <1% | 1,334 | $16K | |
| 81403 | <1% | 113 | $16K | |
| D2335 | <1% | 17 | $16K | |
| J2515 | Injection, pentobarbital sodium, per 50 mg | <1% | 430 | $16K |
| 87493 | <1% | 430 | $16K | |
| D0272 | Bitewings - two radiographic images | <1% | 1,951 | $16K |
| 73564 | <1% | 861 | $16K | |
| 86664 | <1% | 1,577 | $16K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 6,167 | $16K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 101 | $15K |
| 71555 | <1% | 36 | $15K | |
| 80164 | <1% | 1,033 | $15K | |
| 87808 | <1% | 4,776 | $15K | |
| 0082A | <1% | 405 | $15K | |
| 51600 | <1% | 199 | $15K | |
| 90732 | <1% | 414 | $14K | |
| 99403 | <1% | 52 | $14K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 49 | $14K |
| L3060 | Foot, arch support, removable, premolded, longitudinal/ metatarsal, each | <1% | 724 | $14K |
| 93000 | <1% | 732 | $14K | |
| 87529 | <1% | 785 | $14K | |
| 90717 | <1% | 95 | $14K | |
| D7111 | <1% | 28 | $14K | |
| 81244 | <1% | 328 | $14K | |
| 73000 | <1% | 943 | $14K | |
| 83615 | <1% | 2,392 | $13K | |
| 95957 | <1% | 135 | $13K | |
| 94770 | <1% | 185 | $13K | |
| 73060 | <1% | 905 | $13K | |
| 84590 | <1% | 1,344 | $13K | |
| 51727 | <1% | 42 | $13K | |
| 93226 | <1% | 195 | $13K | |
| 87071 | <1% | 1,679 | $13K | |
| 73660 | <1% | 734 | $13K | |
| 84252 | <1% | 1,481 | $13K | |
| 80320 | <1% | 496 | $13K | |
| 96101 | <1% | 91 | $13K | |
| 84270 | <1% | 1,081 | $13K | |
| 92524 | <1% | 187 | $13K | |
| 0051A | <1% | 368 | $13K | |
| 93971 | <1% | 134 | $12K | |
| 88237 | <1% | 113 | $12K | |
| 76010 | <1% | 810 | $12K | |
| 81382 | <1% | 48 | $12K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 4,898 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 368 | $12K |
| D0240 | <1% | 1,420 | $12K | |
| 88188 | <1% | 346 | $12K | |
| 75561 | <1% | 13 | $12K | |
| 80169 | <1% | 610 | $12K | |
| 84295 | <1% | 3,938 | $12K | |
| 84155 | <1% | 1,918 | $12K | |
| 82948 | <1% | 971 | $12K | |
| 76642 | <1% | 103 | $11K | |
| 36430 | <1% | 84 | $11K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 37 | $11K |
| 76857 | <1% | 98 | $11K | |
| 93296 | <1% | 306 | $11K | |
| P9037 | Platelets, pheresis, leukocytes reduced, irradiated, each unit | <1% | 20 | $11K |
| 84446 | <1% | 1,194 | $11K | |
| 92583 | <1% | 339 | $11K | |
| 81243 | <1% | 330 | $10K | |
| 82379 | <1% | 869 | $10K | |
| 95199 | <1% | 747 | $10K | |
| 84075 | <1% | 2,045 | $10K | |
| 84132 | <1% | 4,020 | $10K | |
| J1815 | Injection, insulin, per 5 units | <1% | 707 | $10K |
| 81265 | <1% | 50 | $10K | |
| 69200 | <1% | 332 | $10K | |
| 82627 | <1% | 701 | $10K | |
| 87536 | <1% | 441 | $10K | |
| 87177 | <1% | 474 | $10K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 106 | $10K |
| 92228 | <1% | 120 | $10K | |
| 87265 | <1% | 958 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,837 | $10K |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 201 | $10K |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 3,527 | $10K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 5,677 | $10K |
| D1206 | Topical application of fluoride varnish | <1% | 623 | $10K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 10,925 | $10K |
| 86317 | <1% | 382 | $10K | |
| 93225 | <1% | 195 | $10K | |
| 00940 | <1% | 40 | $10K | |
| 81259 | <1% | 46 | $10K | |
| 85384 | <1% | 1,811 | $9K | |
| 76800 | <1% | 62 | $9K | |
| 86308 | <1% | 1,184 | $9K | |
| 73562 | <1% | 612 | $9K | |
| 99156 | <1% | 621 | $9K | |
| 76499 | <1% | 238 | $9K | |
| 73620 | <1% | 592 | $9K | |
| 88230 | <1% | 87 | $9K | |
| 73110 | <1% | 378 | $9K | |
| 92550 | <1% | 73 | $9K | |
| 0052A | <1% | 226 | $8K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 435 | $8K |
| 12013 | <1% | 43 | $8K | |
| 84703 | <1% | 2,133 | $8K | |
| 85018 | <1% | 2,517 | $8K | |
| 90380 | <1% | 615 | $8K | |
| 72147 | <1% | 39 | $8K | |
| 0173A | <1% | 221 | $8K | |
| 31575 | <1% | 28 | $8K | |
| 88187 | <1% | 500 | $8K | |
| 82310 | <1% | 1,422 | $8K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 111 | $8K |
| 81226 | <1% | 76 | $8K | |
| 93017 | <1% | 57 | $8K | |
| D7240 | Removal of impacted tooth - completely bony | <1% | 12 | $7K |
| 58300 | <1% | 55 | $7K | |
| 87522 | Neg quan hep c or qual rna | <1% | 298 | $7K |
| 90849 | <1% | 41 | $7K | |
| 96113 | <1% | 593 | $7K | |
| 90381 | <1% | 783 | $7K | |
| 81225 | <1% | 89 | $7K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 4,339 | $7K |
| 86141 | <1% | 670 | $7K | |
| 84466 | <1% | 921 | $7K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 10,514 | $7K |
| 86644 | <1% | 208 | $7K | |
| 80230 | <1% | 532 | $7K | |
| 83498 | <1% | 694 | $7K | |
| 91319 | <1% | 634 | $7K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 855 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,087 | $6K |
| 82525 | <1% | 631 | $6K | |
| 82043 | <1% | 1,939 | $6K | |
| 82397 | <1% | 871 | $6K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 157 | $6K |
| 96111 | <1% | 45 | $6K | |
| 80306 | <1% | 887 | $6K | |
| 80195 | <1% | 331 | $6K | |
| 86800 | <1% | 656 | $6K | |
| 87481 | <1% | 313 | $6K | |
| 82272 | <1% | 609 | $6K | |
| 84480 | <1% | 568 | $6K | |
| 87209 | <1% | 474 | $6K | |
| 0073A | <1% | 163 | $6K | |
| 86353 | <1% | 49 | $6K | |
| 84630 | <1% | 791 | $6K | |
| 84484 | <1% | 739 | $6K | |
| 73600 | <1% | 311 | $6K | |
| 0003A | <1% | 156 | $6K | |
| 85250 | <1% | 407 | $6K | |
| 82436 | <1% | 602 | $6K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,501 | $6K |
| 91318 | <1% | 554 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 44 | $5K |
| D0120 | Dental checkup, returning patient | <1% | 291 | $5K |
| 92612 | <1% | 28 | $5K | |
| 84300 | <1% | 925 | $5K | |
| 73080 | <1% | 119 | $5K | |
| 90691 | <1% | 369 | $5K | |
| 82747 | <1% | 749 | $5K | |
| 82465 | <1% | 2,134 | $5K | |
| 83992 | <1% | 512 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 48 | $5K |
| 84478 | <1% | 1,386 | $5K | |
| 86225 | <1% | 586 | $5K | |
| A9573 | Injection, gadopiclenol, 1 ml | <1% | 434 | $5K |
| 74220 | <1% | 61 | $5K | |
| 0053A | <1% | 136 | $5K | |
| 83021 | <1% | 247 | $5K | |
| 76376 | <1% | 95 | $5K | |
| 84238 | <1% | 254 | $5K | |
| 82040 | <1% | 1,145 | $5K | |
| 86255 | <1% | 411 | $4K | |
| 76942 | <1% | 132 | $4K | |
| 92060 | <1% | 76 | $4K | |
| S9443 | Lactation classes, non-physician provider, per session | <1% | 4,231 | $4K |
| 82378 | <1% | 237 | $4K | |
| 00635 | <1% | 142 | $4K | |
| 82150 | <1% | 959 | $4K | |
| 82390 | <1% | 564 | $4K | |
| 96900 | <1% | 162 | $4K | |
| 86337 | <1% | 320 | $4K | |
| 96401 | <1% | 59 | $4K | |
| 86341 | <1% | 389 | $4K | |
| 82103 | <1% | 382 | $4K | |
| 87269 | <1% | 277 | $4K | |
| 86235 | <1% | 316 | $4K | |
| 84255 | <1% | 319 | $4K | |
| 85045 | <1% | 1,130 | $4K | |
| 80183 | <1% | 392 | $4K | |
| 93786 | <1% | 211 | $4K | |
| 43760 | <1% | 12 | $4K | |
| 80329 | <1% | 1,016 | $4K | |
| 90474 | <1% | 7,787 | $4K | |
| 84702 | <1% | 270 | $3K | |
| 84436 | <1% | 458 | $3K | |
| 84133 | <1% | 628 | $3K | |
| 71100 | <1% | 78 | $3K | |
| 87272 | <1% | 278 | $3K | |
| 17250 | <1% | 17 | $3K | |
| 84550 | <1% | 954 | $3K | |
| 87088 | <1% | 791 | $3K | |
| 0174A | <1% | 87 | $3K | |
| 29450 | <1% | 26 | $3K | |
| 86677 | <1% | 220 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 229 | $3K |
| 82140 | <1% | 262 | $3K | |
| 70496 | <1% | 15 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,063 | $3K |
| 96376 | <1% | 336 | $3K | |
| 93886 | <1% | 12 | $3K | |
| 82657 | <1% | 250 | $3K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 1,134 | $3K |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 879 | $3K |
| 85347 | <1% | 758 | $3K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 5,189 | $3K |
| 86703 | <1% | 1,031 | $3K | |
| 73700 | <1% | 13 | $3K | |
| 83010 | <1% | 164 | $3K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 16 | $3K |
| 96203 | <1% | 914 | $3K | |
| 82565 | <1% | 419 | $2K | |
| 86787 | <1% | 186 | $2K | |
| 84681 | <1% | 303 | $2K | |
| 80201 | <1% | 289 | $2K | |
| 80177 | <1% | 198 | $2K | |
| 92626 | <1% | 29 | $2K | |
| 80323 | <1% | 588 | $2K | |
| 30901 | <1% | 13 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 463 | $2K |
| D2332 | <1% | 15 | $2K | |
| 75565 | <1% | 34 | $2K | |
| 01830 | <1% | 34 | $2K | |
| 95714 | <1% | 23 | $2K | |
| 93356 | <1% | 77 | $2K | |
| 89051 | <1% | 488 | $2K | |
| 82010 | <1% | 221 | $2K | |
| 84425 | <1% | 197 | $2K | |
| 82104 | <1% | 270 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 41 | $2K |
| 85230 | <1% | 136 | $2K | |
| 86431 | <1% | 231 | $2K | |
| 00790 | <1% | 14 | $2K | |
| 87101 | <1% | 583 | $2K | |
| 81470 | <1% | 14 | $2K | |
| 86769 | <1% | 43 | $2K | |
| 95712 | <1% | 29 | $2K | |
| 96139 | <1% | 939 | $2K | |
| 86902 | <1% | 81 | $2K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | <1% | 455 | $2K |
| 85270 | <1% | 172 | $2K | |
| 90713 | <1% | 235 | $2K | |
| 80325 | <1% | 554 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 974 | $2K |
| 29105 | <1% | 49 | $2K | |
| 84134 | <1% | 167 | $2K | |
| 85397 | <1% | 109 | $2K | |
| 95012 | <1% | 221 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 195 | $2K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 1,132 | $2K |
| 86645 | <1% | 97 | $2K | |
| 85379 | <1% | 290 | $2K | |
| 96102 | <1% | 12 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 25 | $2K |
| 82139 | <1% | 138 | $2K | |
| 83921 | <1% | 147 | $1K | |
| 84520 | <1% | 539 | $1K | |
| 80353 | <1% | 520 | $1K | |
| 80348 | <1% | 509 | $1K | |
| 82805 | <1% | 15 | $1K | |
| 85576 | <1% | 40 | $1K | |
| 84210 | <1% | 151 | $1K | |
| 0083A | <1% | 35 | $1K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 217 | $1K |
| 83935 | <1% | 274 | $1K | |
| 87106 | <1% | 281 | $1K | |
| 87075 | <1% | 340 | $1K | |
| 77081 | <1% | 31 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $1K |
| 73120 | <1% | 50 | $1K | |
| 86015 | <1% | 125 | $1K | |
| 94729 | <1% | 28 | $1K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 113 | $1K |
| 01480 | <1% | 28 | $998.43 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 2,667 | $984.83 |
| 36416 | <1% | 1,218 | $981.18 | |
| 88104 | <1% | 63 | $949.85 | |
| 86880 | <1% | 74 | $941.91 | |
| 80158 | <1% | 80 | $937.72 | |
| 96160 | <1% | 31 | $914.50 | |
| 80345 | <1% | 121 | $880.90 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 14 | $869.31 |
| 80346 | <1% | 223 | $862.66 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 585 | $855.50 |
| 82540 | <1% | 94 | $854.02 | |
| 76981 | <1% | 12 | $852.43 | |
| 84165 | <1% | 60 | $843.76 | |
| S9485 | Crisis intervention mental health services, per diem | <1% | 32 | $818.94 |
| 94680 | <1% | 31 | $817.88 | |
| 87181 | <1% | 74 | $797.50 | |
| 92604 | <1% | 28 | $789.94 | |
| 86592 | <1% | 116 | $771.00 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 12 | $768.47 |
| 0012A | <1% | 26 | $751.34 | |
| 76937 | <1% | 18 | $744.19 | |
| 73565 | <1% | 12 | $704.96 | |
| 80178 | <1% | 30 | $703.40 | |
| 99453 | <1% | 18 | $699.24 | |
| 01400 | <1% | 25 | $689.38 | |
| 86618 | <1% | 71 | $671.63 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 341 | $656.66 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,316 | $644.99 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 387 | $618.20 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 2,473 | $605.84 |
| 51741 | <1% | 25 | $575.13 | |
| 76882 | <1% | 26 | $565.42 | |
| 96381 | <1% | 928 | $564.36 | |
| 30300 | <1% | 61 | $547.12 | |
| 80358 | <1% | 121 | $527.92 | |
| 01730 | <1% | 14 | $499.84 | |
| 87210 | <1% | 381 | $499.02 | |
| 00930 | <1% | 19 | $489.72 | |
| 80369 | <1% | 121 | $484.94 | |
| 83090 | <1% | 93 | $482.44 | |
| 86828 | <1% | 14 | $475.92 | |
| 72149 | <1% | 16 | $469.66 | |
| 88348 | <1% | 15 | $451.65 | |
| 0151A | <1% | 13 | $441.54 | |
| 80364 | <1% | 149 | $437.93 | |
| 86708 | <1% | 60 | $431.88 | |
| 86705 | <1% | 15 | $419.81 | |
| 80175 | <1% | 34 | $419.07 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 230 | $416.92 |
| 0011A | <1% | 63 | $411.64 | |
| 69209 | <1% | 247 | $409.84 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 2,251 | $408.91 |
| 86735 | <1% | 36 | $400.04 | |
| 88311 | <1% | 52 | $393.31 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 152 | $388.10 |
| 96121 | <1% | 45 | $366.00 | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 12 | $354.63 |
| 86765 | <1% | 35 | $335.65 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 157 | $327.32 |
| 83695 | <1% | 24 | $327.18 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 919 | $320.44 |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 12 | $311.79 |
| D0140 | Limited oral evaluation - problem focused | <1% | 12 | $311.64 |
| 96133 | <1% | 65 | $305.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,085 | $282.86 |
| 00830 | <1% | 29 | $282.28 | |
| 80145 | <1% | 18 | $281.35 | |
| 95873 | <1% | 35 | $278.95 | |
| 83721 | <1% | 47 | $276.54 | |
| 82653 | <1% | 15 | $272.04 | |
| 82180 | <1% | 34 | $261.61 | |
| 83883 | <1% | 29 | $249.94 | |
| 76377 | <1% | 14 | $210.68 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 145 | $205.95 |
| J0736 | Injection, clindamycin phosphate, 300 mg | <1% | 84 | $196.52 |
| 86762 | <1% | 16 | $193.85 | |
| 92608 | <1% | 67 | $187.99 | |
| 80203 | <1% | 26 | $185.65 | |
| 83919 | <1% | 13 | $178.95 | |
| 84207 | <1% | 18 | $145.60 | |
| 82085 | <1% | 50 | $145.06 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 21 | $120.84 |
| 82945 | <1% | 15 | $117.14 | |
| 82017 | <1% | 15 | $115.16 | |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | <1% | 50 | $104.75 |
| 84220 | <1% | 12 | $103.85 | |
| 80361 | <1% | 47 | $99.57 | |
| 88738 | <1% | 16 | $98.28 | |
| 70210 | <1% | 27 | $85.81 | |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | <1% | 96 | $85.31 |
| 80356 | <1% | 47 | $84.92 | |
| 80373 | <1% | 47 | $84.92 | |
| 80360 | <1% | 47 | $84.92 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 683 | $81.83 |
| 87339 | <1% | 38 | $81.60 | |
| 80365 | <1% | 47 | $59.08 | |
| 85999 | <1% | 55 | $58.63 | |
| 80363 | <1% | 27 | $55.13 | |
| 80357 | <1% | 47 | $54.95 | |
| 80341 | <1% | 47 | $54.95 | |
| 80371 | <1% | 47 | $54.95 | |
| 80359 | <1% | 47 | $54.95 | |
| 80368 | <1% | 47 | $54.95 | |
| 80355 | <1% | 47 | $54.95 | |
| 80334 | <1% | 47 | $54.95 | |
| 80344 | <1% | 47 | $54.95 | |
| 80372 | <1% | 47 | $54.95 | |
| 80337 | <1% | 47 | $54.95 | |
| 80366 | <1% | 47 | $54.95 | |
| 80338 | <1% | 47 | $54.95 | |
| J0834 | Injection, cosyntropin, 0.25 mg | <1% | 17 | $54.11 |
| 93568 | <1% | 23 | $53.09 | |
| 85300 | <1% | 14 | $52.23 | |
| 80347 | <1% | 27 | $50.35 | |
| 91300 | <1% | 4,974 | $44.07 | |
| 91307 | <1% | 4,529 | $43.73 | |
| J9250 | Methotrexate sodium, 5 mg | <1% | 129 | $41.90 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 356 | $41.83 |
| 85670 | <1% | 13 | $34.28 | |
| 80370 | <1% | 27 | $32.24 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 25 | $13.51 |
| 91308 | <1% | 1,230 | $11.40 | |
| 91305 | <1% | 1,054 | $9.55 | |
| 91312 | <1% | 1,066 | $8.52 | |
| 91315 | <1% | 739 | $6.78 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 16 | $6.24 |
| 91317 | <1% | 252 | $2.35 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 13 | $0.71 |
| 91301 | <1% | 83 | $0.39 | |
| 96168 | 0% | 282 | $0.00 | |
| 87081 | 0% | 13 | $0.00 | |
| 96159 | 0% | 385 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROOMALL, JODIANNE (SR DIRECTOR BILLING & CODING SERV)
| Provider | Location | Paid |
|---|---|---|
| Children's Hospital Medical Center | Cincinnati, OH | $56.97M |
| Children's Hospital Medical Center | Cincinnati, OH | $51.16M |
| Children's Hospital Medical Center | Cincinnati, OH | $19.19M |
| Children's Hospital Medical Center | Cincinnati, OH | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.